BeiGene, Ltd. (ONC)
NASDAQ: ONC · Real-Time Price · USD
255.37
+11.17 (4.57%)
Feb 21, 2025, 4:00 PM EST - Market closed
BeiGene Employees
BeiGene had 10,600 employees as of December 31, 2023. The number of employees increased by 1,600 or 17.78% compared to the previous year.
Employees
10,600
Change (1Y)
1,600
Growth (1Y)
17.78%
Revenue / Employee
$316,161
Profits / Employee
-$80,606
Market Cap
27.25B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
ONC News
- 9 days ago - BeiGene to Announce Fourth Quarter and Full Year 2024 Financial Results on February 27 - Business Wire
- 11 days ago - BostonGene Collaborates with BeiGene to Advance Biomarker Discovery in Mantle Cell Lymphoma - Business Wire
- 4 weeks ago - 3 Biotech Stocks With Notable Insider Buying - Seeking Alpha
- 6 weeks ago - BeiGene Announces Appointment of Giancarlo Benelli as Head of Europe - Business Wire
- 2 months ago - TEVIMBRA Approved in U.S. for First-line Treatment of Gastric and Gastroesophageal Junction Cancers in Combination with Chemotherapy - Business Wire
- 2 months ago - BeiGene to Change Nasdaq Ticker Symbol to “ONC” on January 2; Present at 43rd Annual J.P. Morgan Healthcare Conference - Business Wire
- 2 months ago - BeiGene Announces Global Licensing Agreement for MAT2A Inhibitor - Business Wire
- 2 months ago - BeiGene Advances Leadership in CLL at ASH 2024 with New Data From Its Hematology Franchise Including BRUKINSA® and Novel Pipeline Assets - Business Wire